8-K
Current Report
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001193125-15-228037
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d947400d8k.htm…